(Q77984791)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10400478%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

title

A six-month, placebo-controlled comparison of the safety and efficacy of salmeterol or beclomethasone for persistent asthma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10400478%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference

Nathan RA

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10400478%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Pinnas JL

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10400478%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Schwartz HJ

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10400478%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Grossman J

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10400478%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Yancey SW

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10400478%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Emmett AH

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10400478%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

Rickard KA

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10400478%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

publication date

1 June 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10400478%20AND%20SRC:MED&resulttype=core&format=json

Annals of Allergy, Asthma & Immunology

10 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10400478%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

volume

82

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10400478%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10400478%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

page(s)

521-529

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10400478%20AND%20SRC:MED&resulttype=core&format=json

Asthma control during and after cessation of regular beta 2-agonist treatment

10 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963159-6

7 January 2021

An overview of nine clinical trials of salmeterol in an asthmatic population

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963159-6

7 January 2021

A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963159-6

7 January 2021

One year treatment with salmeterol compared with beclomethasone in children with asthma. The Dutch Paediatric Asthma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963159-6

7 January 2021

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963159-6

7 January 2021

Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963159-6

7 January 2021

Standardization of spirometry: a summary of recommendations from the American Thoracic Society. The 1987 update

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963159-6

7 January 2021

A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963159-6

7 January 2021

Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963159-6

7 January 2021

Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963159-6

7 January 2021

Effect of long-term treatment with salmeterol on asthma control: a double blind, randomised crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963159-6

7 January 2021

Twelve months, treatment with inhaled salmeterol in asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963159-6

7 January 2021

Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963159-6

7 January 2021

Tolerance to the protective effects of salmeterol on methacholine-induced bronchoconstriction: influence of inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963159-6

7 January 2021

Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963159-6

7 January 2021

10.1016/S1081-1206(10)63159-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10400478%20AND%20SRC:MED&resulttype=core&format=json

10 December 2019

1 reference